Basic Information
Hybridize Therapeutics Develops RNA-Based Therapies for Acute and Chronic Kidney Disease Patients
Hybridize Therapeutics
SouthHolland,Netherlands
less than 15 people
January 01, 2019
info@hybridizetherapeutics.com